Nowcasting by Bayesian Smoothing: A flexible, generalizable model for real-time epidemic tracking.


Journal

PLoS computational biology
ISSN: 1553-7358
Titre abrégé: PLoS Comput Biol
Pays: United States
ID NLM: 101238922

Informations de publication

Date de publication:
04 2020
Historique:
received: 24 06 2019
accepted: 17 02 2020
revised: 16 04 2020
pubmed: 7 4 2020
medline: 15 7 2020
entrez: 7 4 2020
Statut: epublish

Résumé

Achieving accurate, real-time estimates of disease activity is challenged by delays in case reporting. "Nowcast" approaches attempt to estimate the complete case counts for a given reporting date, using a time series of case reports that is known to be incomplete due to reporting delays. Modeling the reporting delay distribution is a common feature of nowcast approaches. However, many nowcast approaches ignore a crucial feature of infectious disease transmission-that future cases are intrinsically linked to past reported cases-and are optimized to one or two applications, which may limit generalizability. Here, we present a Bayesian approach, NobBS (Nowcasting by Bayesian Smoothing) capable of producing smooth and accurate nowcasts in multiple disease settings. We test NobBS on dengue in Puerto Rico and influenza-like illness (ILI) in the United States to examine performance and robustness across settings exhibiting a range of common reporting delay characteristics (from stable to time-varying), and compare this approach with a published nowcasting software package while investigating the features of each approach that contribute to good or poor performance. We show that introducing a temporal relationship between cases considerably improves performance when the reporting delay distribution is time-varying, and we identify trade-offs in the role of moving windows to accurately capture changes in the delay. We present software implementing this new approach (R package "NobBS") for widespread application and provide practical guidance on implementation.

Identifiants

pubmed: 32251464
doi: 10.1371/journal.pcbi.1007735
pii: PCOMPBIOL-D-19-01045
pmc: PMC7162546
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1007735

Subventions

Organisme : NIAID NIH HHS
ID : T32 AI007535
Pays : United States
Organisme : NIGMS NIH HHS
ID : U54 GM088558
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Biosecur Bioterror. 2011 Jun;9(2):89-115
pubmed: 21612363
BMC Public Health. 2004 Feb 14;4:2
pubmed: 15028111
Biometrics. 2014 Dec;70(4):993-1002
pubmed: 24930473
Aust N Z J Public Health. 1998 Jun;22(4):432-5
pubmed: 9659768
Comput Appl Biosci. 1992 Dec;8(6):579-81
pubmed: 1468015
J Public Health Policy. 1989 Summer;10(2):187-203
pubmed: 2745711
Sci Rep. 2016 Sep 26;6:33707
pubmed: 27665707
Biometrics. 1994 Dec;50(4):1203-14
pubmed: 7787003
Stat Med. 2019 Sep 30;38(22):4363-4377
pubmed: 31292995
Sci Rep. 2019 Jan 24;9(1):683
pubmed: 30679458
Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14473-8
pubmed: 26553980
Am J Epidemiol. 2004 Sep 15;160(6):509-16
pubmed: 15353409
Epidemiology. 2019 Sep;30(5):737-745
pubmed: 31205290
Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):3146-3154
pubmed: 30647115
Biom J. 2015 Nov;57(6):1051-67
pubmed: 26250543

Auteurs

Sarah F McGough (SF)

Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, United States of America.

Michael A Johansson (MA)

Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.

Marc Lipsitch (M)

Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.

Nicolas A Menzies (NA)

Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH